UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody

Clinical cancer research, 2005-08, Vol.11 (16), p.5920-5927

2005

Volltextzugriff (PDF)

Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer

Clinical cancer research, 2005-10, Vol.11 (19), p.7187s-7194s

2005

Volltextzugriff (PDF)

Acetaminophen and diphenhydramine as premedication for platelet transfusions: A prospective randomized double‐blind placebo‐controlled trial

American journal of hematology, 2002-07, Vol.70 (3), p.191-194

2002

Volltextzugriff (PDF)

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

Biology of blood and marrow transplantation, 2013-08, Vol.19 (8), p.1238-1243

2013

Volltextzugriff (PDF)

The Addition of Ibritumomab Tiuxetan (IT) to the ATG/TLI Preparative Regimen Is Safe and May Enhance Post-Transplant Response and Outcomes for Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Blood, 2019-11, Vol.134 (Supplement_1), p.3334-3334

2019

Volltextzugriff (PDF)

Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT

Clinical cancer research, 2003-09, Vol.9 (10 Pt 2), p.3938S-44S

2003

Volltextzugriff (PDF)

Acute myocardial infarction in hemoglobin SC disease

Annals of hematology, 2004-10, Vol.83 (10), p.622-624

2004

Volltextzugriff (PDF)

Radioimmunotherapy with 111In/90Y-2IT-BAD-m170 for Metastatic Prostate Cancer

Clinical cancer research, 2001-06, Vol.7 (6), p.1561-1568

2001

Volltextzugriff (PDF)

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN PATIENTS WITH DYSKERATOSIS CONGENITA

Biology of blood and marrow transplantation, 2013-06, Vol.19 (8), p.1238-1243

2013

Volltextzugriff (PDF)

Intensive Care Unit Admissions in Patients with Hematologic Malignancies: Outcomes and Prognostic Indicators

Blood, 2005-11, Vol.106 (11), p.752-752

2005

Volltextzugriff (PDF)

Reduced Intensity Stem Cell Transplant (RIST) as Salvage Treatment for Relapse Following Myeloablative Allogeneic Transplantation in Adult Acute Myeloid Leukemia

Blood, 2006-11, Vol.108 (11), p.5374-5374

2006

Volltextzugriff (PDF)

Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies : The promise of monoclonal antibodies for the therapy of cancer

Critical reviews in oncology/hematology, 2001, Vol.38 (1), p.25-35

2001

Volltextzugriff (PDF)

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to lndium-111 /yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody

Clinical cancer research, 2005, Vol.11 (16), p.5920-5927

2005

Volltextzugriff (PDF)

Enhanced Therapeutic Index of Radioimmunotherapy (RIT) in Prostate Cancer Patients

Clinical cancer research, 2003-09, Vol.9 (10), p.3938s

2003

Volltextzugriff (PDF)

Group psychotherapy with the elderly: Problems and prospects

Psychotherapy (Chicago, Ill.), 1982, Vol.19 (4), p.437-443

1982

Volltextzugriff (PDF)

Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation

Journal of clinical oncology, 1994-02, Vol.12 (2), p.342-346

1994

Volltextzugriff (PDF)

Enhancement of the therapeutic index : From non myeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer

Clinical cancer research, 2005, Vol.11 (19), p.7187s-7194s

2005

Volltextzugriff (PDF)

Radioimmunotherapy for Breast Cancer Using Indium-lll/Yttrium-90 BrE-3: Results of a Phase I Clinical Trial

The Journal of nuclear medicine (1978), 1997-08, Vol.38 (8), p.1180

1997

Volltextzugriff (PDF)

Granulocyte/Macrophage Progenitor Cells From Peripheral Blood and Bone Ma rrow Differ in Their Response to Prostaglandin E1

Blood, 1987-12, Vol.70 (6), p.1792-1796

1987

Volltextzugriff (PDF)

Enhancement of Clinical Radioimmunotherapy for Cancer and the Role of Cytokines

JNCI : Journal of the National Cancer Institute, 1992-03, Vol.84 (6), p.374-375

1992

Volltextzugriff (PDF)

The Structured Group Interview as an Evaluation Technique

Evaluation news, 1983-11, Vol.4 (4), p.58-60

1983

Volltextzugriff (PDF)

Differential Protection of Normal and Malignant Human Myeloid Progenitors (CFU-GM) From Ara-C Toxicity Using Cycloheximide

Blood, 1985-10, Vol.66 (4), p.830-834

1985

Volltextzugriff (PDF)

Chronic Myelodysplastic Syndrome (Preleukemia) With the Philadelphia Chromosome

Blood, 1980-08, Vol.56 (2), p.262-264

1980

Volltextzugriff (PDF)

Sequential transplants using mobilized peripheral blood progenitor cells

Journal of clinical apheresis, 1994, Vol.9 (3), p.176-182

1994

Volltextzugriff (PDF)

The effect of lithium carbonate on chemotherapy‐induced neutropenia and thrombocytopenia

American journal of hematology, 1984-05, Vol.16 (4), p.313-323

1984

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Aktive Filter

ThemaRadioimmunotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(73)
Ungarisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody

Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer

Acetaminophen and diphenhydramine as premedication for platelet transfusions: A prospective randomized double‐blind placebo‐controlled trial

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

The Addition of Ibritumomab Tiuxetan (IT) to the ATG/TLI Preparative Regimen Is Safe and May Enhance Post-Transplant Response and Outcomes for Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT

Acute myocardial infarction in hemoglobin SC disease

Radioimmunotherapy with 111In/90Y-2IT-BAD-m170 for Metastatic Prostate Cancer

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN PATIENTS WITH DYSKERATOSIS CONGENITA

Intensive Care Unit Admissions in Patients with Hematologic Malignancies: Outcomes and Prognostic Indicators

Reduced Intensity Stem Cell Transplant (RIST) as Salvage Treatment for Relapse Following Myeloablative Allogeneic Transplantation in Adult Acute Myeloid Leukemia

Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies : The promise of monoclonal antibodies for the therapy of cancer

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to lndium-111 /yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody

Enhanced Therapeutic Index of Radioimmunotherapy (RIT) in Prostate Cancer Patients

Group psychotherapy with the elderly: Problems and prospects

Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation

Enhancement of the therapeutic index : From non myeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer

Radioimmunotherapy for Breast Cancer Using Indium-lll/Yttrium-90 BrE-3: Results of a Phase I Clinical Trial

Granulocyte/Macrophage Progenitor Cells From Peripheral Blood and Bone Ma rrow Differ in Their Response to Prostaglandin E1

Enhancement of Clinical Radioimmunotherapy for Cancer and the Role of Cytokines

The Structured Group Interview as an Evaluation Technique

Differential Protection of Normal and Malignant Human Myeloid Progenitors (CFU-GM) From Ara-C Toxicity Using Cycloheximide

Chronic Myelodysplastic Syndrome (Preleukemia) With the Philadelphia Chromosome

Sequential transplants using mobilized peripheral blood progenitor cells

The effect of lithium carbonate on chemotherapy‐induced neutropenia and thrombocytopenia

Aktive Filter

Suchergebnisse filtern